4//SEC Filing
Farwell Wildon 4
Accession 0000950170-24-022242
CIK 0001818794other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:06 PM ET
Size
4.6 KB
Accession
0000950170-24-022242
Insider Transaction Report
Form 4
Farwell Wildon
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-02-28$25.00/sh−407$10,175→ 163,096 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 14, 2023.
- [F2]Includes 140,510 unvested RSUs.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001847941
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:06 PM ET
- Size
- 4.6 KB